@article{aa7433dcfb0743a7931bc580cfb955bb,
title = "Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus",
abstract = "The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology. The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology.",
author = "Conley, {Robert B.} and Dane Dickson and Zenklusen, {Jean Claude} and {Al Naber}, Jennifer and Messner, {Donna A.} and Ajlan Atasoy and Lena Chaihorsky and Deborah Collyar and Carolyn Compton and Martin Ferguson and Sean Khozin and Klein, {Roger D.} and Sri Kotte and Razelle Kurzrock and Lin, {C. Jimmy} and Frank Liu and Ingrid Marino and Robert McDonough and Amy McNeal and Vincent Miller and Schilsky, {Richard L.} and Wang, {Lisa I.}",
note = "Funding Information: The authors very gratefully thank the American Association for Cancer Research, the American Society of Clinical Oncology, the European Organisation for Research and Treatment of Cancer, Genentech, Genomics England, the National Cancer Institute, and the Oncology Research Information Exchange Network for sharing their data dictionaries. D.D. owns stock in Exelixis and received honoraria for speaking for Novartis. L.C. is employed by Qiagen. S. Kotte is employed by Natera. R.K. has received research funding from Genentech, Merck Serono, Pfizer, Sequenom, Foundation Medicine, and Guardant; has received consultant/advisory board fees from Actuate Therapeutics and Xbiotech; and is a shareholder in Curematch. C.J.L. is employed by and a shareholder in Natera. F.L. is employed by Merck. I.M. and V.M. are employed by and shareholders in Foundation Medicine. A.M. is employed by Biocept. L.I.W. is employed by Genentech and a shareholder in Roche. This work was supported by Ambry Genetics , Amgen , Biocept , Caris , Foundation Medicine , Genentech , Genomic Health , Merck , NantHealth , Natera , and Qiagen . Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",
year = "2017",
month = nov,
day = "16",
doi = "10.1016/j.cell.2017.10.032",
language = "English (US)",
volume = "171",
pages = "982--986",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "5",
}